What's Behind the SPAC Boom?
Kirkland partner Christian Nagler spoke with The New York Times’ DealBook regarding the recent boom in special purpose acquisition companies (SPACs).
“In the life-sciences industry, where SPACs have ‘nearly replaced late-stage financing and I.P.O.s,’ warrants have come down to zero in some deals, said Christian Nagler, a partner in the capital markets practice at the law firm Kirkland & Ellis.”
This article appeared in its entirety in the August 25, 2020, edition of The New York Times.